Researchers say childhood epilepsy and mild attention deficits were effectively “hiding” a case of mild aromatic l-amino acid decarboxylase…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Most people with rare diseases given an experimental therapy through compassionate use programs show clinical benefits, and most of these…
Although AADC deficiency is characterized by low levels of signaling molecules in the brain that impair its normal function,…
PTC Therapeutics will meet with the U.S. Food and Drug Administration (FDA) in December to review the data the company…
The AADC enzyme can undergo a process called phosphorylation at a specific molecular site to increase its activity, a study…
A new artificial intelligence (AI) tool — OpenAI’s GPT application programming interface (API) — has been integrated into FindZebra,…
Most rare disease experts are in favor of using DNA sequencing to screen newborns for AADC deficiency and other…
Children with aromatic L-amino acid decarboxylase (AADC) deficiency are continuing to experience motor function gains up to 10 years…
The case of a girl with unexplained seizures in whom an epilepsy gene panel screening was the key toward a…
IndoUSrare, a U.S.-based humanitarian organization, is working to build international connections between scientists to accelerate research that aims to…